bisnafide and Adenocarcinoma, Basal Cell
bisnafide has been researched along with Adenocarcinoma, Basal Cell in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Behrens, CH; Cheshire, PJ; Dexter, DL; Gross, JL; Hallman, JC; Houghton, JA; Houghton, PJ; McRipley, RJ; Sun, JH | 1 |
Corbett, TH; Dan, M; Demchik, L; Gross, JL; LoRusso, P; Polin, L | 1 |
Other Studies
2 other study(ies) available for bisnafide and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers.
Topics: Adenocarcinoma; Adolescent; Adult; Analysis of Variance; Animals; Antineoplastic Agents; Child; Colonic Neoplasms; Drug Resistance; Female; Humans; Isoquinolines; Mesylates; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Neoplasms; Rhabdomyosarcoma; Topoisomerase I Inhibitors; Treatment Outcome; Tumor Cells, Cultured | 1994 |
Comparative efficacy of DMP 840 against mouse and human solid tumor models.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; In Vitro Techniques; Isoquinolines; Male; Mammary Neoplasms, Animal; Mesylates; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Nude; Tumor Cells, Cultured | 1995 |